Arca
Skip to content
Tools
Tools

Leiomyoma

Drug research and approvals for leiomyoma: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 44 studies of leiomyoma are recruiting on ClinicalTrials.gov, Health Canada has authorized 2 drug trials for it since 2013, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 44
  • Trials authorized in Canada: 2
  • FDA orphan approvals: 0
  • EU medicines: 2

Recruiting now

Newest posted first, of 44 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

  • LinzagolixGonadotropin-releasing hormone receptor antagonist

Phase 3 12 of 13

Phase 2 9

Phase 1 or earlier 4

How its trials ended

443 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 122 whose ending is known, 38% met their primary endpoint, 4% missed it and 58% stopped early.

  • Completed, result not reported17239%
  • Status unknown7918%
  • Ongoing7016%
  • Met its primary endpoint4610%
  • Stopped: other or unclear327%
  • Stopped: enrollment or feasibility164%
  • Stopped: sponsor or business decision123%
  • Stopped: lack of efficacy61%
  • Missed its primary endpoint51%
  • Stopped: funding51%

Trials authorized in Canada

Newest first; search them all in Canada trials
Dec 19, 2013A randomized, placebo-controlled, parallel group, multicenter study to evaluate the efficacy and safety of ulipristal acetate for the treatment of abnormal…FibristalTeva Pharmaceutical IndustriesPending
Aug 21, 2013A randomized, placebo-controlled, parallel group, multicenter study to evaluate the efficacy and safety of ulipristal acetate for the intermittent treatment of…FibristalAbbVieOngoing

Medicines authorised in the EU

Newest first
Jun 14, 2022YseltyLinzagolix cholineTheramex Ireland LimitedEMA ↗
Jul 16, 2021RyeqoRelugolix; estradiol; norethisterone acetateGedeon Richter Plc.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.